{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:44:11Z","timestamp":1768005851307,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genome Var"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Two\n                    <jats:italic>ERLIN2<\/jats:italic>\n                    variants (NM_007175.8:c.660delA and NM_007175.8:c.869C&gt;T) were detected in a Spanish patient with hereditary spastic paraplegia via whole-exome sequencing and software-based pathogenic variant selection. Segregation analysis revealed that the patient\u2019s two affected siblings carried both variants, whereas their offspring, carrying only one variant, were asymptomatic, indicating the autosomal recessive nature of the disease. These findings suggest that the identified variants can be classified as pathogenic when they are present as compound heterozygous variants.\n                  <\/jats:p>","DOI":"10.1038\/s41439-024-00305-9","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T03:39:35Z","timestamp":1736134775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of novel ERLIN2 gene variants with hereditary spastic paraplegia"],"prefix":"10.1038","volume":"12","author":[{"given":"R.","family":"Bermejo Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Villena Gasc\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ruiz Palmero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Ribes Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8264-6512","authenticated-orcid":false,"given":"E. S.","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Piqueras Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Flores Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Buces Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. D.","family":"Arroyo And\u00fajar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"305_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10048-011-0291-8","volume":"12","author":"AM Alazami","year":"2011","unstructured":"Alazami, A. M., Adly, N., Al Dhalaan, H. & Alkuraya, F. S. A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18). Neurogenetics 12, 333\u2013336 (2011).","journal-title":"Neurogenetics"},{"key":"305_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","volume":"126","author":"JK Fink","year":"2013","unstructured":"Fink, J. K. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol. 126, 307\u2013328 (2013).","journal-title":"Acta Neuropathol."},{"key":"305_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/ene.13625","volume":"25","author":"SL Rydning","year":"2018","unstructured":"Rydning, S. L. et al. A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia. Eur. J. Neurol. 25, 943\u2013e71 (2018).","journal-title":"Eur. J. Neurol."},{"key":"305_CR4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00439-015-1536-7","volume":"134","author":"C Tesson","year":"2015","unstructured":"Tesson, C., Koht, J. & Stevanin, G. Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology. Hum. Genet. 134, 511\u2013538 (2015).","journal-title":"Hum. Genet."},{"key":"305_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"JM Park","year":"2020","unstructured":"Park, J. M. et al. An autosomal dominant ERLIN2 mutation leads to a pure HSP phenotype distinct from the autosomal recessive ERLIN2 mutations (SPG18). Sci. Rep. 10, 1\u20136 (2020).","journal-title":"Sci. Rep."},{"key":"305_CR6","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1093\/hmg\/ddr070","volume":"20","author":"Y Yildirim","year":"2011","unstructured":"Yildirim, Y. et al. A frameshift mutation of ERLIN2 in recessive intellectual disability, motor dysfunction and multiple joint contractures. Hum. Mol. Gen. 20, 1886\u20131892 (2011).","journal-title":"Hum. Mol. Gen."},{"key":"305_CR7","doi-asserted-by":"publisher","first-page":"e77940","DOI":"10.1371\/journal.pone.0077940","volume":"8","author":"J Hu","year":"2013","unstructured":"Hu, J. & Ng, P. C. SIFT Indel: predictions for the functional effects of amino acid insertions\/deletions in proteins. PloS One 8, e77940 (2013).","journal-title":"PloS One"},{"key":"305_CR8","first-page":"7","volume":"76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen\u20102. Curr. Protoc. Hum. Genet 76, 7\u201320 (2013).","journal-title":"Curr. Protoc. Hum. Genet"},{"key":"305_CR9","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng, P. C. Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812\u20133814 (2003).","journal-title":"Nucleic Acids Res."},{"key":"305_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejmg.2012.10.003","volume":"56","author":"SM Wakil","year":"2013","unstructured":"Wakil, S. M. et al. A novel splice site mutation in ERLIN2 causes hereditary spastic paraplegia in a Saudi family. Eur. J. Med. Genet. 56, 43\u201345 (2013).","journal-title":"Eur. J. Med. Genet."},{"key":"305_CR11","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.4103\/0366-6999.193444","volume":"129","author":"WT Tian","year":"2016","unstructured":"Tian, W. T. et al. Novel mutations in endoplasmic reticulum lipid raft-associated protein 2 gene cause pure hereditary spastic paraplegia type 18. Chin. Med. J. 129, 2759\u20132761 (2016).","journal-title":"Chin. Med. J."},{"key":"305_CR12","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/acn3.51007","volume":"7","author":"S Srivastava","year":"2020","unstructured":"Srivastava, S. et al. Expansion of the genetic landscape of ERLIN2\u2010related disorders. Ann. Clin. Transl. Neurol. 7, 573\u2013578 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"305_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2395","volume":"11","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. More autosomal dominant SPG18 cases than recessive? The first AD\u2010SPG18 pedigree in Chinese and literature review. Brain Behav. 11, e32395 (2021).","journal-title":"Brain Behav."},{"key":"305_CR14","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1007\/s10072-024-07500-0","volume":"45","author":"A Trinchillo","year":"2024","unstructured":"Trinchillo, A. et al. Expanding SPG18 clinical spectrum: autosomal dominant mutation causes complicated hereditary spastic paraplegia in a large family. Neurol. Sci. 45, 4373\u20134381 (2024).","journal-title":"Neurol. Sci."},{"key":"305_CR15","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1002\/acn3.51902","volume":"10","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. A novel autosomal dominant ERLIN2 variant activates endoplasmic reticulum stress in a Chinese HSP family. Ann. Clin. Transl. Neur 10, 2139\u20132148 (2023).","journal-title":"Ann. Clin. Transl. Neur"},{"key":"305_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10048-018-0545-9","volume":"19","author":"L Travaglini","year":"2018","unstructured":"Travaglini, L. et al. The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes. Neurogenetics 19, 111\u2013121 (2018).","journal-title":"Neurogenetics"},{"key":"305_CR17","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1007\/s10072-024-07423-w","volume":"45","author":"E Cioffi","year":"2024","unstructured":"Cioffi, E. et al. Hereditary spastic paraparesis type 18 (SPG18): new ERLIN2 variants in a series of Italian patients, shedding light upon genetic and phenotypic variability. Neurol. Sci. 45, 3845\u20133852 (2024).","journal-title":"Neurol. Sci."},{"key":"305_CR18","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1007\/s00415-020-10059-3","volume":"267","author":"G McMacken","year":"2020","unstructured":"McMacken, G. et al. Behr syndrome and hypertrophic cardiomyopathy in a family with a novel UCHL1 deletion. J. Neurol. 267, 3643\u20133649 (2020).","journal-title":"J. Neurol."},{"key":"305_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/ana.10059","volume":"51","author":"P Corona","year":"2002","unstructured":"Corona, P. et al. Novel heteroplasmic mtDNA mutation in a family with heterogeneous clinical presentations. Ann. Neurol. 51, 118\u2013122 (2002).","journal-title":"Ann. Neurol."},{"key":"305_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mito.2010.07.006","volume":"11","author":"C Verny","year":"2011","unstructured":"Verny, C. et al. Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation. Mitochondrion 11, 70\u201375 (2011).","journal-title":"Mitochondrion"}],"container-title":["Human Genome Variation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41439-024-00305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41439-024-00305-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41439-024-00305-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T18:01:55Z","timestamp":1767981715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41439-024-00305-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["305"],"URL":"https:\/\/doi.org\/10.1038\/s41439-024-00305-9","relation":{},"ISSN":["2054-345X"],"issn-type":[{"value":"2054-345X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.B.R., N.V.G., L.R.P., G.A.R.B., E.S.Y. and J.D.A.A. had a work contract with Progenie Molecular S.L.U. during this research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was designed and conducted in accordance with the ethical standards of the 1964 Helsinki Declaration and Spanish Law 14\/2007. This study was approved by the Research Ethics Committee of the Universitat de Val\u00e8ncia (September 10, 2020). Written informed consent was obtained from all the participants of this study to perform genetic tests and to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"3"}}